Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 15;59(7):257-263.
doi: 10.2176/nmc.st.2019-0034. Epub 2019 May 11.

Macrophage Imaging of Intracranial Aneurysms

Affiliations
Review

Macrophage Imaging of Intracranial Aneurysms

Kampei Shimizu et al. Neurol Med Chir (Tokyo). .

Abstract

Considered with a poor outcome of subarachnoid hemorrhage due to rupture of intracranial aneurysms (IAs), treatment interventions to prevent rupture of the lesions are mandatory for social health. As treatment option is limited to surgical manipulations, like microsurgical clipping, endovascular coiling or deployment of flow diverter, and these surgical interventions have a potential risk of complications in nature, a proper selection of rupture-prone IAs among ones incidentally found is essential. Today, a rupture risk in each case is estimated by several factors like patient characteristics and morphological ones of each lesion. However, unfortunately, an IA without treatment sometimes unexpectedly ruptures resulting in a devastating outcome or an IA surgically treated is turned out to have a thick wall. To achieve more efficient treatment interventions, the development of a novel diagnostic modality is required. Here, mainly through the accumulation of experimental findings, the crucial contribution of macrophage-mediated chronic inflammatory responses to IA progression have been revealed, making macrophage being a promising target for a diagnosis. If we could non-invasively visualize accumulation of macrophages in lesions, this imaging technique 'macrophage imaging' may enable a qualitative evaluation of IAs to stratify rupture-prone 'dangerous' lesions among many stable ones. Thereby, a development of macrophage imaging makes an indication of surgical interventions being more accurate and also greatly facilitates a development of a novel medical therapy if used as a surrogate marker.

Keywords: chronic inflammation; ferumoxytol; imaging; intracranial aneurysm; macrophage.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest Disclosure

All authors have no conflicts of interest and registered online Self-reported COI Disclosure Statement Forms through the website for The Japan Neurosurgical Society.

Figures

Fig. 1
Fig. 1
The schematic drawing of the concept of macrophage imaging. Nano-particles are injected to a patient with an intracranial aneurysm and macrophages in a lesion engulfing these particles are visualized by MRI. The lesion with enhancement is stratified as an ‘active’ one.
Fig. 2
Fig. 2
Macrophage imaging by an iron-containing nanoparticle, ferumoxytol. (A) Electron microscopic imaging of RAW264.7 cells, a mouse macrophage cell line, engulfing ferumoxytol. Cultured Raw264.7 cells were treated with ferumoxytol and subjected to an electron microscopic observation. Magnified image of RAW264.7 cells engulfing ferumoxytol is shown in the right panel. (B) One example of macrophage imaging of human case with a cavernous aneurysm by ferumoxytol. 2D-Gradient echo MR images were acquired before (pre) and 24 h after (post) the administration of macrophage imaging. Subtracted image is shown in the right panel. Note the presence of several hypo-intensity signals in the aneurysm wall. Images in this figure were originally published in citation as Figs. 2A and 4A (B). Written permission regarding the reuse of these images in this figure was acquired.

Similar articles

Cited by

References

    1. Vlak MH, Algra A, Brandenburg R, Rinkel GJ: Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 10: 626–636, 2011 - PubMed
    1. Aoki T, Nozaki K: Preemptive medicine for cerebral aneurysms. Neurol Med Chir (Tokyo) 56: 552–568, 2016 - PMC - PubMed
    1. Greving JP, Wermer MJ, Brown RD, et al. : Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol 13: 59–66, 2014 - PubMed
    1. Kotowski M, Naggara O, Darsaut TE, et al. : Safety and occlusion rates of surgical treatment of unruptured intracranial aneurysms: a systematic review and meta-analysis of the literature from 1990 to 2011. J Neurol Neurosurg Psychiatry 84: 42–48, 2013 - PubMed
    1. Ishibashi T, Murayama Y, Urashima M, et al. : Unruptured intracranial aneurysms: incidence of rupture and risk factors. Stroke 40: 313–316, 2009 - PubMed

MeSH terms